Orion Capital Management LLC
1330 Orange Ave., Ste 302
Coronado, CA 92118
p: 619-319-0520
f: 855-691-0427
Join Our Newsletter
Read financial tips and market updates in our weekly newsletter
Copyright © 2002 – 2023 Orion Capital Management LLC • Coronado, CA
Disclosure: Orion Capital Management LLC (“Orion”) is an investment advisor registered with the U.S. Securities and Exchange Commission (SEC). The firm offers advisory services in the State of California and in other jurisdictions where registered or exempted. Registration does not imply a certain level of skill or training. The information on Orion’s website or in its distributed commentary shall not be directly or indirectly interpreted as a solicitation of investment advisory services to persons or entities of another jurisdiction unless otherwise permitted by statute. Orion’s individualized responses to consumers in a particular state in the rendering of personalized investment advice for compensation shall not be made without the firm first complying with jurisdiction requirements or pursuant to an applicable state exemption.
The information on Orion’s website or in its distributed commentary is not investment, tax, accounting or legal advice. Orion is not a tax advisor. For tax advice individuals should consult their CPA. This information is also not an offer or a solicitation of an offer to buy or sell any security, or to be construed as an endorsement of any company, security, fund, or other securities or non-securities offering. This information should not be relied upon in the making of investment decisions. All content on this site is for informational purposes only, and nothing herein should be construed as an investment recommendation. Opinions expressed herein are solely those of Orion, unless otherwise specifically cited. Material presented is believed to be from reliable sources, but no representations are made by our firm as to other parties’ informational accuracy or completeness. All information or ideas described on Orion’s website or in its distributed commentary should be discussed in detail with an investor’s personal financial advisors and legal counsel prior to implementation.
Past performance is no indication of future results. Investment in securities involves significant risk and has the potential for partial or complete loss of funds invested.
The information on Orion’s website or in its distributed commentary is provided “AS IS” and without warranties of any kind, either express or implied. To the fullest extent permissible pursuant to applicable laws, Orion Capital Management LLC disclaims all warranties, express or implied, including, but not limited to, implied warranties of merchantability, non-infringement, and suitability for a particular purpose.
Testimonials or reviews on Orion’s website are from current clients. Orion does not compensate for reviews or testimonials and has no material conflicts with clients offering reviews.
Orion does not warrant that the information on Orion’s website or in its distributed commentary will be free from error. Your use of this information is at your sole risk. Under no circumstances shall Orion be liable for any direct, indirect, special or consequential damages that result from the use of, or the inability to use, the information provided on this site, even if Orion or an Orion authorized representative has been advised of the possibility of such damages. Information contained on this site should not be considered a solicitation to buy or an offer to sell any security, or a recommendation to buy or sell any security in any jurisdiction where such offer, solicitation, or recommendation would be unlawful or unauthorized.
Investors Get a Shot of Confidence
As I write this piece on November 13th, two seemingly incongruous events are taking place. First, Covid-19 is on the rampage in the U.S. as never before, with a record 165,000 new cases being recorded today (after only having reached a 100,000 new case rate just eight days ago). Given this alarming acceleration in the rate of spread, lockdowns are likely to be announced in the coming weeks in many areas of the country and local economies are unfortunately going to suffer. The human cost will also be very, very painful for the country in the coming months. Meanwhile, the U.S. stock market is having a great November and closed today at an all-time high. What is going on???
The Big Event for Investors (No, Not the Election.)
Some analysts attribute much of the strong performance of equity markets in November so far to the fact that Election Day came and went without major unrest around the country and that President-Elect Joe Biden will likely have to tangle with a Republican-controlled Senate. The election was certainly a risk factor for many investors, and plenty had raised cash ahead of November 3rd. Now that this potential risk has been cleared, a relief rally in the markets seemed in order as investors flooded back in to replenish their positions.
In our view, however, by far the most important recent news for the markets was the November 9th announcement of interim efficacy data for the vaccine candidate that New York-based Pfizer and Germany-based BioNTech are advancing: their vaccine was found to be more that 90% effective in preventing the spread of Covid-19. If this vaccine should eventually work as well in the general population as it is working with the 43,538 participants in the Pfizer/BioNTech Phase 3 clinical study, it is practically impossible to overstate the momentous implication of this discovery. Not only will this vaccine save many, many lives that would have been lost to Covid-19 in the coming months and years, but it will ultimately enable the global economy, and indeed humanity itself, to come back to life.
The Beginning of the End for Covid-19
To us, it seems investors are basically saying, collectively, that they believe that the Pfizer/BioNTech (and other) vaccines now in the pipeline represent the beginning of the end of the Covid-19 pandemic. Of course, there are many things that need to happen logistically, in terms of further vaccine testing, production, distribution and administration, for the vaccine to put a stop to the spread of Covid-19, but markets appear to be signaling that the tide is turning on the pandemic.
Investors Betting Life Comes Back in 2021
While the overall markets have sprinted higher so far in November, the complexion of the rally is also telling. In the months after markets hit bottom on March 23rd, technology stocks and other “work-from-home” stocks led the way higher, far outperforming more economically sensitive asset classes, such as small- and mid-cap stocks, and sectors such as financials, industrials and energy. November, so far, has been the reverse as investors apparently reposition for our economy to reawaken in 2021.
Despite the encouraging progress on vaccines and therapeutics, the worst of the pandemic is probably still ahead of us, unfortunately. Given the infection rates now, however, the next few months will be a grim stretch for the country as we cope with a flood of cases. We hope everyone is staying safe and well.
Please call or email if you would like to discuss your investment strategy.
You can also schedule a meeting with us here:
Image: Canva.com
Share This!
Join Our list!
Join our email newsletter list to receive more market updates and financial articles like this one.
The Fed and Jackson Hole
Fed to Present Update at Jackson Hole on Friday In the year since Federal Reserve Chairman Jerome Powell’s last speech
Soft Landing Back in Play
Soft Landing Hopes Rising A “soft landing,” a scenario in which the Federal Reserve tames inflation through interest rate hikes
Markets Calm Amid Crosscurrents
Both stock and bond markets seem to be taking today’s many conflicting financial and political cross currents in stride, with
Peter Thoms, CFA, MBA